28. Design, Synthesis and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Anti-angiogenic Activities 

Hong, S.; Kim, J.; Seo, J.; Jung, K.; Hong, S.-S.; Hong, S.

J. Med. Chem. 2012, 55, 5337-5349.

27. The Effect of HS-111, a Novel Thiazolamine Derivative, on Apoptosis and Angiogenesis of Hepatocellular Carcinoma Cells 

Choi, M.-J.; Lee, H.; Lee, J.-H.; Jung, K. H.; Kim, D.; Hong, S.*; Hong, S.-S.*

Arch. Pharm. Res. 2012, 35, 747-754.

26. Structure-Based Virtual Screening Approach to the Discovery of p38 MAP Kinase Inhibitors 

Choi, H.; Park, H.; Shin, J. C.; Ko, H. S.; Lee, J. K.; Lee, S.; Park, H.; Hong, S.

Bioorg. Med. Chem. Lett. 2012, 22, 2195-2199.

​25. Direct C–H Cross-Coupling Approach to Heteroaryl Coumarins 

Min, M.; Kim, B.; Hong, S.

Org. Biomol. Chem. 2012, 10, 2692-2698. (Top ten most accessed article)

24. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway 

Jung, K. H.; Choi, M.-J.; Hong, S.; Lee, H.; Hong, S.-W.; Zheng, H.-M.; Lee, H. S.; Hong, S.*; Hong, S.-S.*

Cancer Lett. 2012, 316, 187-195.

23. Structure-Based De Novo Design and Biochemical Evaluation of Novel BRAF Kinase Inhibitors 

Park, H.; Jeong, Y.; Hong, S.

Bioorg. Med. Chem. Lett. 2012, 22. 1027. 

22. Nocodazole is a High-Affinity Ligand for the Cancer-Related Kinases ABL, c-KIT, BRAF, and MEK 

Park, H.; Hong, S.; Hong, S.

ChemMedChem. 2012, 7, 53-56.

21. A Novel Imidazopyridine Analogue as a Phosphatidylinositol 3-Kinase Inhibitor against Human Breast Cancer 

Lee, H.; Li, G.-Y.; Jeong, Y.; Jung, K. H.; Lee, J.-H.; Ham, K.; Hong, S.*; Hong, S.-S.*

Cancer Lett. 2012, 318, 68.

20. Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure 

Park, H.; Chi, O.; Kim, J.;  Hong, S.

J. Chem. Inform. Mod. 2011, 51, 2986-2993.